VTT, Turku University Hospital and Gothenburg University studying how gut microbes affect on progression of type 1 diabetes

The project is motivated by VTT's discovery of early metabolic signatures predictive of later progression to autoimmunity and type 1 diabetes. These metabolic signatures suggest the potential role of gut microbiota in early T1D pathogenesis.

Therefore, in this project the aim is to discover specific microbes or lack of them associated with later progression to T1D, and to utilize that information for developing new prevention strategies. If the tests for the prevention strategies are successful the intervention can be considered for clinical stages.

The project is initiated and coordinated by Prof. Matej Orešiè from VTT. It combines expertise in systems biology and metabolomics (VTT), clinical type 1 diabetes research (Prof. Olli Simell and his group from the Turku University Hospital and the Finnish Type 1 Diabetes Prediction and Prevention Study DIPP), and microbiology (Prof. Fredrik Bäckhed, University of Gothenburg).

The project “The gut microbiota as a novel target for prevention of type 1 diabetes” is coordinated by VTT and it is funded by the Juvenile Diabetes Research Foundation in USA.

It has been recently reported (Harjutsalo V, Sjöberg L, Tuomilehto J. Lancet. 2008;371: 1777-82) that based on current trends the incidence of type 1 diabetes in Finland will double within next 15 years and the age of onset will be younger (0-4 years). T1D is and will be therefore a major healthcare issue in Finland, and increasingly also in other Western countries. Discovery of preventive therapies capable of preventing or delaying the onset of type 1 diabetes would thus have major implications for healthcare.

Further information:

VTT
Research Professor Matej Orešiè
tel. +358 40 705 5156, matej.oresic@vtt.fi
Further information on VTT:
Senior Vice President
Olli Ernvall
Tel. +358 20 722 6747
olli.ernvall@vtt.fi
VTT Technical Research Centre of Finland is the biggest contract research organization in Northern Europe. VTT provides high-end technology solutions and innovation services. From its wide knowledge base, VTT can combine different technologies, create new innovations and a substantial range of world-class technologies and applied research services, thus improving its clients' competitiveness and competence. Through its international scientific and technology network, VTT can produce information, upgrade technology knowledge and create business intelligence and value added to its stakeholders.

Media Contact

Professor Matej Orešiè VTT

More Information:

http://www.vtt.fi/?lang=en

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Superradiant atoms could push the boundaries of how precisely time can be measured

Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…

Ion thermoelectric conversion devices for near room temperature

The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…

Zap Energy achieves 37-million-degree temperatures in a compact device

New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…

Partners & Sponsors